Sugentech Inc. (KOSDAQ:253840)
4,995.00
+40.00 (0.81%)
Jun 5, 2026, 3:30 PM KST
Sugentech Revenue
Sugentech had revenue of 2.35B KRW in the quarter ending March 31, 2026, with 24.18% growth. This brings the company's revenue in the last twelve months to 9.87B, down -1.52% year-over-year. In the year 2025, Sugentech had annual revenue of 9.42B, down -6.74%.
Revenue (ttm)
9.87B
Revenue Growth
-1.52%
P/S Ratio
7.73
Revenue / Employee
68.57M
Employees
144
Market Cap
76.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.42B | -680.23M | -6.74% |
| Dec 31, 2024 | 10.10B | 2.96B | 41.57% |
| Dec 31, 2023 | 7.13B | -94.27B | -92.97% |
| Dec 31, 2022 | 101.40B | 24.20B | 31.34% |
| Dec 31, 2021 | 77.20B | 35.85B | 86.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 122.78B |
| Osang Healthcare Co.,Ltd | 119.38B |
| Ray Co., Ltd. | 112.53B |
| Bio Plus | 94.42B |
| LabGenomics | 84.19B |
| T&R Biofab | 29.73B |
| HASS Corp. | 16.58B |
| P&S Robotics | 8.55B |